4//SEC Filing
Chipman Christopher Michael 4
Accession 0000905718-22-000182
CIK 0001708331other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:00 PM ET
Size
5.3 KB
Accession
0000905718-22-000182
Insider Transaction Report
Form 4
Chipman Christopher Michael
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-31+100,000→ 100,000 totalExercise: $2.13Exp: 2032-01-31→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option vests in three equal annual installments commencing on January 31, 2023.
Documents
Issuer
Virpax Pharmaceuticals, Inc.
CIK 0001708331
Entity typeother
Related Parties
1- filerCIK 0001354941
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 5:00 PM ET
- Size
- 5.3 KB